Phase 1 study of galunisertib, a TGF-beta receptor I kinase inhibitor, in Japanese patients with advanced solid tumors
暂无分享,去创建一个
H. Utsumi | T. Tamura | K. Ogasawara | N. Yamamoto | H. Nokihara | H. Asou | I. Gueorguieva | Y. Fujiwara | K. Sunami | O. Takahashi | Y. Yamada